HARE JOSHUA M has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are UNIV ROUEN NORMANDIE, CT DE RECH PUBLIC DE LA SANTE and STATENS INST FOR FOLKEHELSE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Computer technology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Hare Joshua M | 12 |
#2 | Kittleson Michelle M | 7 |
#3 | Mcniece Ian K | 3 |
#4 | Landin Ana Marie | 1 |
#5 | Heidecker Bettina | 1 |
Publication | Filing date | Title |
---|---|---|
AU2011293144A1 | Bone marrow derived CD271 precursor cells for cardiac repair | |
US2012142544A1 | Diagnostic transcriptomic biomarkers in inflammatory cardiomyopathies | |
US2006246484A1 | Identification of gene expression by heart failure etiology | |
EP1704224A2 | Identification of a gene expression profile that differentiates ischemic and nonischemic cardiomyopathy |